Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Pharmacokinetics
87%
Early Phase Clinical Trials
87%
Anticancer Agents
87%
Molecular Targets
87%
Phase I Trial
58%
Metabolism
58%
Phase II Trial
58%
Pharmacodynamics
58%
Antineoplastic Agents
58%
Pharmacodynamic Difference
33%
Science Studies
33%
Ameliorating Agent
33%
Special Patient Population
33%
Mechanism of Drug Action
33%
Patient Demographics
29%
National Cancer Institute
29%
Effective Dose
29%
Absorption Distribution
29%
Pharmacologic
29%
Treatment Regimen
29%
Maximum Tolerated Dose
29%
Pharmacogenomic Studies
29%
Cellular Level
29%
Radio
29%
Biological Mechanisms
29%
Heavily Pretreated Patients
29%
Enzyme Targets
29%
Investigational Agents
29%
Effect Mechanism
29%
Correlative Science
29%
Pharmacokinetic Differences
29%
Clinical Utilization
29%
Mechanism of Action
29%
In Cancer
29%
Nuclear Imaging
29%
Ethnic Groups
29%
Organ Function
29%
Pharmacology
29%
Laboratory Science
29%
Metabolic Pathway
29%
MR Spectroscopic Imaging (MRSI)
29%
Pharmacokinetic Drug Interactions
29%
Antitumor Agents
29%
Information Integration
29%
Grant Applications
29%
Race Groups
29%
CSF-1
29%
Drug-metabolizing Enzymes
29%
Patients with Advanced Cancer
29%
Geriatric Patients
29%
Drug Target
29%
Non-invasive Method
29%
Difference Basis
29%
Clinical Toxicity
29%
Molecular Targeted Agents
29%
Clinical Levels
29%
Pharmacology, Toxicology and Pharmaceutical Science
Anticarcinogen
100%
Clinical Trial
100%
Pharmacokinetics
83%
Pharmacodynamics
66%
Molecular Target
50%
Malignant Neoplasm
33%
Phase II Trials
33%
Phase I Trials
33%
Colony Stimulating Factor
16%
Drug Metabolizing Enzyme
16%
Drug Action
16%
Pharmacogenomics
16%
Elimination
16%
Biological Marker
16%
Advanced Cancer
16%
Maximum Tolerated Dose
16%